Related Experiment Video
Updated: Sep 23, 2025
08:06
Robotic Cochlear Implantation for Direct Cochlear Access
Published on: June 16, 2022
3.4K
Cochlear implantation in a 16-month-old with Chudley-McCullough Syndrome
Grant Kalil1, Shelby Barrera2, Alex Elkins2
1The University of Mississippi Medical Center, School of Medicine, 2500 North State St., Jackson, MS 39216, United States of America.
American Journal of Otolaryngology
|May 15, 2022
Summary
Bilateral cochlear implantation (CI) is safe and effective for pediatric patients with Chudley-McCullough Syndrome (CMS). Early detection and treatment of hearing loss in CMS are crucial for preventing speech and language delays.
Area of Science:
- Otolaryngology
- Genetics
- Pediatrics
Background:
- Chudley-McCullough Syndrome (CMS) is a rare genetic disorder.
- Sensorineural hearing loss is a common manifestation of CMS.
- Early diagnosis and intervention are critical for managing CMS-related hearing loss.
Observation:
- A 16-month-old female with CMS presented with bilateral sensorineural hearing loss after failing a newborn hearing screen.
- Hearing amplification was unsuccessful.
- The patient underwent bilateral cochlear implantation (CI).
Findings:
- The bilateral CI surgery was successful with no complications.
- Post-implantation, the patient demonstrated satisfactory speech and language development.
- This case highlights the efficacy of CI in pediatric CMS patients.
Implications:
- Cochlear implantation is a safe and effective treatment for hearing loss in pediatric CMS.
- Early identification and management of hearing impairment in CMS can prevent developmental delays.
- This case contributes to understanding the clinical presentation and management of CMS.
